Doctor Sara Chiaretti

Meet our researchers

A photo of Sara Chiaretti

Dr Sara Chiaretti

Research Fellow
Population health, donor research and cellular therapies 

Adjunct Fellow -University of the Sunshine Coast, Adjunct Fellow-The University of Queensland

Connect with Dr Chiaretti
Email LinkedIn Research Gate
Sara is a translational researcher specialising in erythropoiesis and neonatal transfusion, leading the development of cord blood–derived therapies for use in neonatal intensive care. She partners with hospitals across Australia and contributes to international collaborations driving product development. 

 

With a PhD in Experimental Medicine and Oncology and over 15 years’ experience spanning academia and industry, she brings strong expertise in cell biology and therapeutic innovation. Sara serves on the ISBT Clinical Transfusion Working Party (paediatric subgroup) and the ANZSBT Clinical Transfusion Practice Committee, to advance paediatric transfusion care and clinical impact.
Leadership
  • Member of International Society of Blood Transfusion (ISBT) Working Party: Clinical Transfusion - Paediatrics subgroup
  • Member of Australia & New Zealand Society of Blood Transfusion (ANZSBT) Clinical Transfusion Practice committee
  • Member of Association Italian Researcher in Australasia
  • Supervisor of PhD, Master and Honours students

     
Awards
  • ANZSBT Presidential Symposium awards (2025)

Key publications

Human neutrophil antigen 3 genotype impacts neutrophil-mediated endothelial cell cytotoxicity in a two-event model of TRALI

Chiaretti S, Burton M, Hassel P, Radenkovic F, Devikashri N, Sultana AJ, Temple FT, Dean MM, Tung JP
2022
Blood Transfusion
20(6):465-474
View publication

Transfusion-related acute lung injury (TRALI): Potential pathways of development, strategies for prevention and treatment, and future research directions

Tung JP, Chiaretti S, Dean MM, Reade MC, Fung YL
2022
Blood reviews
53:100926
View publication

Recovery of organ-specific tissue oxygen delivery at restrictive transfusion thresholds after fluid treatment in ovine haemorrhagic shock

Dyer WB, Simonova G, Chiaretti S, Bouquet M, Wellburn R, Heinsar S, Ainola C, Wildi K, Sato K, Livingstone S, Suen JY, Irving DO, Tung JP, Li Bassi G, Faser JF
2022
Intensive Care Med Exp
10(1):12
View publication

*Effects of the scaffold proteins liprin-α1, β1 and β2 on invasion by breast cancer cells

Chiaretti S, Astro V, Chiricozzi E, de Curtis I
2016
Biology of the Cell
108(3): 65-75
View publication

*Liprin-α1 and ERC1 control cell edge dynamics by promoting focal adhesion turnover

Astro V, Tonoli D, Chiaretti S, Badanai S, Sala K, Zerial M, DeCurtis I
2016
Scientific Reports
6(1): 1-16
View publication

* This research was completed prior to starting with Lifeblood